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Abstract 
The existence of relationship between economic variables has always been an object 
of study within the scientific community. The aim of this paper is to investigate the 
relationship between public and private (household) health expenditure 
(macroeconomic and microeconomic approach) over time and within recession and 
austerity period in Greece, in order to find out whether the strict Memorandum health 
policies pass, influence or go along with health expenditure to the end consumer, i.e. 
the health services user. In this context, by using econometric tools such as multiple 
regression and co-integration analysis on the raw micro-data of Household Budget 
Surveys of 1987/88 till 2018, as well as using data of public expenditure of OECD- 
Health Statistics 2019, in the STATA vs 13, we examined the actual impact of financial 
crisis in Greece. Analysis demonstrated that the Greek HHE was rapidly increasing 
during 1988-2008, when it started decreasing. The results indicate that total Private 
and the total Public Health expenditure seems to have a bidirectional long run 
relationship and significant co-integration. So, does the public expenditure with the 
household medical services expenditure and pharmaceuticals. Furthermore, the 
results indicate that over the years of recession, the monthly household health 
expenditure decreases, due to confiscation of middle-class income which led to 
consumerism restrictions. However, as households are now spending a bigger portion 
of their shrunken income for health (as health is an inelastic commodity), HHE, as a 
proportion of total private expenditure, has eventually risen. 
 
Keywords: Health & healthcare spending, Greece, Household health expenditure, 
Recession, Austerity, Financial Crisis Impact, Economic Adjustment, Household Budget 
Survey (E.O.P), Multiple co-intergation 
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Introduction 
The study of health expenditure in multiple periods of time is a difficult task which has 
to consider both the fact that health is a product of inelastic demand, and also that 
public sector has a role of "payer" and therefore the power to regulate market prices. 
Financial fluctuations, therefore, can affect providers, users and, ultimately, 
population’s health. 
 
Health sector in Greece, after a period of growth, within the first decade of the 
millennium when Total Expenditure on Health (% GDP, 2009) to exceed 10% (above 
the EU average), then it began to moderate. After signing the Memorandum of 
Understanding (M.S. / Greece: Memorandum of Understanding on specific economic 
policy conditionality, 2010) in 2010, a number of urgent, expenditure restricting 
measures and structural reforms were imposed to the Greek health sector and, in 
particular, to pharmaceutical sector. The last one seems to significantly contribute 
(negatively) to both deficit and public debt, due to excessive public spending and lack 
of control in both volume and cost of prescriptions. 
 
Therefore, in May 2010, pharmaceutical industry became the focus of fiscal 
consolidation and was one of the main areas of intervention in order to reduce public 
pharmaceutical expenditure to 1% of GDP, thus approaching the European average 
(European Commission, 2010). As a result, public pharmaceutical expenditure 
decreased by 44% between 2009 and 2012, reaching 2.8 billion Euros, corresponding 
to 1.5% of GDP in 2012 (Foundation for Economic and Industrial Research/ IOBE, 
2014). 
 
Coupled with the economy contraction, health expenditure in Greece has been also 
reduced proportionally from 9.8% of GDP in 2008 to 8.1% in 2014 (Vlachadis et al., 
2014). Reduced health costs, required under the austerity program, have been 
criticized because they do not contain specific provisions to safeguard the NHS 
(Vlachadis et al., 2014), a system established in the 1980s as part of the national 
compulsory social security program, through which most of Greek inhabitants have 
been cared. However, as mentioned above, Greece has failed to control health 
spending between 2000 and 2009, and the health budget deficit of the country 
reached 50 billion Euro (Liaropoulos, 2012). Consequently, at the beginning of the 
crisis, the health sector was set to be a priority by the Troika, having contributed 
significantly to the economic derailing of the country. 
 
This paper studies the level of public health expenditure and private Greek HHE within 
the period 1988-2018. Additionally, the existence of interaction between public and 
private expenditure was examined by using the method of co-integration, in order to 
determine whether a change in Greek public health spending has ultimately the same 
behavior with the variation of private household health expenditure. The survey 
results will provide an enlightening insight into the evolution of health expenditure in 
Greece for the past 30 years and through the evolution of the costs, the impact of the 
financial crisis will be determined. 
 
Material and Methods 
In the present study pre-form (raw) data derived from the Greek Statistical Authority 
(ELSTAT), concerning private health expenditure from the Household Budget Surveys 
(HBS) of year 1987, 1994, 1999, 2004, and annually from 2008 to 2018. We should 
bear in mind that HBS are carried out at random and at regular basis1, by ELSTAT, 
throughout Greek territory. Through these surveys, information on consumer 
spending, income, housing facilities, consumer durables and household socio-
economic characteristics and its members are collected. In regard to health 
expenditure, HBS records, inter alia, households’ responses to pharmaceuticals 
expenditure-treatment-equipment devices, non-hospital medical and hospital care 
services, not individually, but on household level, since household in-charge-person 
reflects the costs and consumer behaviors of entire household. Additionally, data 
were drawn from the Organization for Economic Co-operation and Development 
(OECD- Health Statistics, 2019) on the level of public expenditure over time as a 
percentage of GDP. Health spending refers to the final consumption of goods and use 
of health services (ie current health expenditure), including personal therapeutic care 
                                                 
1 every four years previously on an annual basis from 2008 onwards 
(curative care, rehabilitation, long-term nursing care, ancillary health care services and 
medical products, prevention and public health services, as well as healthcare 
administrative costs, excluding investment and research- education costs).  
 
It should be noted, here, that Health expenditures in Greece are financed through a 
combination of funding agencies, including public spending and mandatory health 
insurance (“Government / mandatory”) and private health insurance; private funds, 
such as out-of-pocket household payments, NGOs expenditures etc. 
 
Data analysis was performed via STATA software, version 13, and for research 
purposes the technique of co-integration analysis was used.  
 
Co-integration hypothesis 
A set of time series co-integrates when there is a linear combination of these time 
series which are stationary; this combination cannot present a stochastic trend. The 
linear time series combination is the equation of co-integration that represent the 
long-term equilibrium relationship among these sequences. For the purposes of co-
integration test, variables must be stationary at the same level. Co-integration test 
was performed via Johansen test (1988) in order to examine if there is co-integration 
between variables. 
We therefore define the hypothesis:  
 
Ho: There is no co-integration between variables. 
Ha: There is co-integration 
 
If time series are co-integrated, it means that long-term variables move together on 
the same direction without, however, meaning that in short-term occurs the same. 
The test shows if there are, and how many, linear co-integration relations between 
the controlled variables. The link between short-term and long-term relationship of 
variables is performed by the existence of co-integration, as a prerequisite for 
assessing the Vector Error Correction Model. If the findings show that in our model 
there is, indeed, co-integration relationship, it allows the assessment of the VEC model 
(Vector Error Correction). Thence VEC model is used, because we want to 
simultaneously examine the results of the regressions relating to linear equations. 
 
All assays were performed in 5% level of significance (a = 0.05). 
 
Results 
1. Descriptive presentation of household health expenditure categories  
 
Table 1 and Figure 1 portray the longitudinal data on the average monthly household 
expenditure for Medicines, therapeutic appliances and equipment. The results are 
given both for the total average cost and their subcategories. Furthermore, it should 
be noted that until 2008 no data were available regarding these three cost categories 
separately. 
 
Table 1: Average monthly expenditure on Medicines, Therapeutic apparatus and 
Equipment of Greek households, during the period 1988-2018 
Year 
Medicines, 
Therapeutic 
apparatus and 
Equipment 
Pharmaceutical 
products (1) 
Other 
medicines (2) 
Therapeutic 
apparatus and 
Equipment (3) 
1988 3.56 - - - 
1994 10.4 - - - 
1999 17.6 - - - 
2004 25.54 - - - 
2008 33.02 27.36 1.50 4.16 
2009 31.25 25.83 1.97 3.44 
2010 32.23 27.44 1.87 2.91 
2011 30.84 25.33 1.73 3.77 
2012 32.52 28.69 1.42 2.40 
2013 37.13 33.8 1.57 1.76 
2014 39.85 35.75 2.45 1.64 
2015 39.60 35.98 0.38 1.54 
2016 39.10 35.67 0.31 1.18 
2017 38.78 35.37 0.28 1.13 
2018 38.96 35.45 0.27 1.12 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
Graph 2 shows that the average total household expenditure in Medicines, 
Therapeutic apparatus and Equipment increases rapidly from the year 1988 to the 
year 2018. The increase reaches 994.38%, as from EUR 3.56 in 1988 reached 38.96 
EUR in 2018. Furthermore, the graph shows that within 2008-2011 (financial crisis) the 
average monthly household spending had a downward trend compared to previous 
years, while in the period 2012 to 2018 it began to rise again at considerable pace. 
Additionally, the results showed that the biggest proportion of the category 
“Medicines, Therapeutic apparatus and Equipment” expenditure comes from the 
medicines expenditure. In contrast, the “Other Therapeutic apparatus and Equipment” 
household expenditure seem to be stagnant and declining from 2004 to 2018. 
Graph 2: Evolution of expenditure on Medicines, Therapeutic apparatus and 
Equipment of Greek households, during the period 1988-2018, in Euro
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
In Table 2 and Graph 3 are presented the temporal data on the average monthly 
household expenditure on Medical Services (Outpatient). The results are shown both 
for total average cost of medical services, and for its subcategories. Furthermore, it 
should be noted that there are overall figures with respect to the classification of 
expenditure in subcategories only after 2004. 
 
Table 2: Average monthly expenditure on Medical Services (Outpatient) of Greek 
households, during the period 1988-2018, in Euro 
Year 
Medical 
Services 
(Outpatient) 
Medical  
services 
Dental services  
Paramedical 
services 
1988 14 - - - 
1994 30 13.5 16.5 - 
1999 54.42 22.38 32.04 - 
2004 69.76 29.85 39.91 - 
2008 87.54 30.07 42.30 15.17 
2009 79.48 26.96 39.45 13.07 
2010 67.30 22.45 33.25 11.59 
2011 57.09 19.84 26.65 10.59 
2012 43.54 14.94 19.73 8.87 
2013 38.15 12.27 16.81 9.08 
2014 35.63 11.52 15.8 8.31 
2015 33.54 11.71 14.23 7.60 
2016 31.83 11.67 13.19 6.97 
2017 32.03 11.83 14.02 6.19 
2018 33.18 12.74 14.02 6.41 
Source: ELSTAT (HBS raw data of 1988-2018) 
 Graph 3 shows that the average monthly total household expenditure on medical 
services had been increasing from 1988 to 2008 (growth rate of 525.29%, from EUR 
14 in 1988 to EUR 87,54 in 2008). In contrast, within the period 2008-2018 the average 
monthly total household expenditure on medical services appeared to have a 
declining trend from EUR 87.54 in 2008, to EUR 33.18 in 2018, that is a 62.1% decrease. 
Additionally, the results showed that since the beginning of the financial crisis in 2008 
the average household expenditure for medical services had a downward trend 
compared to the previous ones. Moreover, the biggest part of expenditure for medical 
services derives from dental services. In contrast, paramedical services expenditure 
seems to have been stagnant and declining from 2004 to 2018, while it happens to be 
the smallest percentage among three subcategories of medical expenses. 
 
Graph 3: Evolution of expenditure on Medical Services (Outpatient) of Greek 
households, during the period 1988-2018, in Euro 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
As refers to paramedical Greek household services, particularly, from HBS data of year 
1987, 1994, 1999, 2004 and 2008 to 2018, it is shown that the biggest portion of 
expenditure for paramedical services is related to microbiological laboratory services 
and radiology centers, followed by paramedical staff services, while a very small 
percentage is attributable to other- non-hospital services. Table 14 and Graph 48 
below, indicate a common and constant reduction of costs in all three subcategories 
over the years. 
 
Table 3: Average monthly expenditure on Paramedical Services of Greek households, 
during the period 1988-2018, in Euro 
Year 
Paramedical 
Services 
Microbiological 
laboratory services 
and radiology 
centers 
Paramedical 
staff services 
Other-  
non-hospital 
services 
2008 15.17 9.99 4.64 0.55 
2009 13.07 8.78 4.06 0.23 
2010 11.59 7.71 3.56 0.32 
2011 10.59 7.08 3.20 0.31 
2012 8.87 6.50 2.01 0.37 
2013 9.08 6.83 1.91 0.34 
2014 8.31 6.03 1.98 0.3 
2015 7.60 5.69 0.23 0.13 
2016 6.97 5.31 0.14 0.03 
2017 6.19 4.19 0.1 0.07 
2018 6.41 4.18 0.09 0.06 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
Graph 4: Evolution of paramedical expenditure and subcategories of Greek 
households, during the period 1988-2018, in Euro 
 Source: ELSTAT (HBS raw data of 1988-2018) 
 
Next category of health expenditure relates to Hospital Care and analytical results are 
presented on Table 4 and Graph 5 below. The results show that the average monthly 
expenditure of Greek households for hospital care increased steadily over the period 
1988-2018. Specifically, the average cost of hospitalization from EUR 3,1 in 1988 
increased to EUR 35,85 in 2018, which is equal to an increase of 1056.45% 
(approximately tenfold average expenditure). As refers to subcategories of hospital 
care, it is noticed that the highest average contribution to total hospital care has the 
private hospital care where it is impossible to separate accommodation services and 
health services (medical or paramedical) followed by public hospital and private 
hospital care (accommodation, nutrition, etc.). From the subcategories of hospital 
care expenditure, the most important finding is that private hospital care expenditure 
where it is impossible to separate accommodation services and health services 
(medical or paramedical) increases considerably over the years, while other categories 
show either stagnation or decline. 
 
It is also noticed that within the period 2008-2018, the average private hospital care 
where it is impossible to separate accommodation services and health services 
(medical or paramedical) expenditure increased from EUR 6.34 to EUR 24.66 (growth 
rate 288.96%), while the average monthly expenditure for private hospital care 
(accommodation, food, etc.) decreased from EUR 6.08 to EUR 3.03 (reduction rate 
50.16%) and average monthly expenditure for private hospital care (doctor’s services 
and fees) decreased from EUR 2.91 to EUR 1.54 (reduction rate 47.08%). 
 
Table 4: Average monthly expenditure on hospital care of Greek households, 
 during the period 1988-2018, in Euro 
Year Hospital care 
Public hospital 
care 
V1 V2 V3 V4 
1988 3.1 - - - - - 
1994 7.8 - - - - - 
1999 11.66 - - - - - 
2004 18.44 - - - - - 
2008 21.54 5.93 6.08 2.91 0.29 6.34 
2009 23.55 6.06 6.62 3.82 0.33 6.71 
2010 24.90 7.11 5.24 4.32 0.17 8.05 
2011 26.66 7.62 5.67 4.22 1.01 8.14 
2012 28.66 8.12 5.71 4.57 1.24 9.02 
2013 29.16 8.15 4.21 4.33 1.13 11.35 
2014 31.25 8.85 3.73 1.55 0.22 16.9 
2015 34.22 8.88 4.47 1.27 0.26 19.34 
2016 32.75 6.90 4.18 1.32 0.40 19.95 
2017 32.51 6.25 2.58 0.94 0.43 22.3 
2018 35.85 6 3.03 1.54 0.62 24.66 
❖ V1= Private hospital care (accommodation, nutrition etc),  
❖ V2= Private hospital care (doctor’s services and fees), 
❖ V3= Private hospital care (medical analysis, paramedical services),  
❖ V4= Private hospital where it is impossible to seperate accommodation services and health 
care services (medical or paramedical) 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
Graph 5: Evolution of hospital care expenditures of Greek households,  
during the period 1988-2018, in Euro 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
2. Descriptive presentation of total health expenditure 
 
Findings concerning the total HHE for the period 1988-2018 and its three main 
subcategories of expenditure (medical, pharmaceutical, hospital) are shown below. 
Graph 6 shows that total monthly HHE in Greece had an upward trend during the 
period 1988-2008. Specifically, total monthly expenditures from EUR 20,66 in 1988 
reached EUR 142.1 in 2008, which refers to an increase of 587.8% (fivefold increase 
on expenditure). On the contrary, from the beginning of financial crisis till 2018, the 
average monthly total household expenditure declined from EUR 142.1 in 2008 to 
EUR 107.99 in 2018, that is a reduction of 24%. Furthermore, as follows, up to the 
beginning of the financial downturn in 2008, the bulk of total health expenditure 
derives from medical expenditure, while from 2008 onwards medical costs had a 
decrease of 62.1%. Then, from 2012 onwards this kind of costs equilibrated to 
pharmaceutical costs and expenditures for hospital care. Lastly, another important 
finding is that after 2008, spending on medical services seems to be largely affected, 
while pharmaceutical costs and expenditures for hospital care appeared to have a 
small but steady increase (percentage 17.99% and 66.43% respectively). 
 
 
Graph 6: Evolution of total health expenditures and its main subcategories (medical, 
pharmaceutical, hospital) of Greek households, during the period 1988-2018, in Euro 
 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
 
3. Descriptive presentation of public health expenditure as percentage of GDP  
 
Here are the findings regarding public health expenditure as a percentage of GDP of 
Greece. The results of the study are illustrated in Graph 7, proving that public spending 
had an increasing trend within the period 1988 to 2010, when the percentage of 
health expenditure to GDP rose from 3% to 6.6%, while from 2010 to 2018 we 
observed a sharp reduction in public spending due to the implementation of fiscal 
adjustment strict measures, from 6.6% to 4.7% of GDP. 
 
 
 
Graph 7: Evolution of public health expenditure as a percentage of GDP,  
1988-2018, Greece 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
 
4. Joint presentation of household health expenditure and public health expenditure 
development (multiple co-integration) 
 
Graph 8 shows both, simultaneously, HHE and public health expenditure 
development. According to it, private household expenditure seems to go hand in 
hand with public expenditure, since, as mentioned above, total household spending 
appears to have a strong growth during the period 1988-2008 and a significant 
reduction during the period 2008-2018. Total public expenditure shows, also, strong 
growth during the period 1988-2010 and significant reduction in the period 2010-
2018.  
 
 
 
 
 
Graph 8: Evolution of public health expenditure as a percentage of GDP and Greek 
household health expenditure, 1988-2018 
 
Source: OECD Health Statistics, 2019 & ELSTAT (HBS raw data of 1988-2018) 
 
5. Co-integration analysis results between public health spending and Greek 
household health expenditure 
 
In the last section of results are presented data regarding integration of HHE to public 
expenditure as a percentage of GDP. Due to few observations (which does not allow 
us to draw reliable conclusions), Johansen test does not yield results in the total data 
set and therefore, it was chosen to apply integration test between public health 
expenditure and total private health expenditure (Table 5) and between public health 
expenditure and the two main categories of private health expenses (medical and 
pharmaceutical). 
 
Table 5 shows that for r = 0, the null hypothesis is rejected (since trace statistic > 
critical value) and this means that we reject the hypothesis of co-integration equation 
absence. Conversely, for r = 1, the null hypothesis is not rejected (2.16 < critical value 
= 3.74) and we do not reject the null hypothesis that there is only one co-integration 
equation.  
 This means that there is a co-integration relationship between public health 
spending and private health expenditure. 
 
Table 5: Co-integration analysis results between public health spending 
and Greek household health expenditure 
 
 
Source: OECD Health Statistics, 2019 & ELSTAT (HBS raw data of 1988-2018) 
 
Subsequently, co-integration equation was evaluated and the multivariate model/ 
error correction model VEC (Vector Error Correction Model or otherwise ECVAR) and 
the results are detailed in Table 6 below.  
 
The co-integration equation is: 
 𝑬𝑪𝑻𝒕−𝟏 = 𝟒. 𝟔𝟑𝟓 + 𝑯𝒐𝒖𝒔𝒆𝒉𝒐𝒍𝒅 𝑯𝑬  𝒕−𝟏 − 𝟐𝟐. 𝟖𝟑𝟐 ∙ 𝑷𝒖𝒃𝒍𝒊𝒄 𝑯𝑬𝒕−𝟏 
VEC indicates that long-run equilibrium equations are: 
 𝛥(𝑃𝑢𝑏𝑙𝑖𝑐 𝐻𝐸)𝑡  = −0.718 ∙ 𝐸𝐶𝑇𝑡−1  + 1.826 ∙ 𝑃𝑢𝑏𝑙𝑖𝑐 𝐻𝐸 𝑡−1 + 2.218∙ 𝐻𝑜𝑢𝑠𝑒ℎ𝑜𝑙𝑑 𝐻𝐸 𝑡−1 − 0.0002 𝛥(𝐻𝑜𝑢𝑠𝑒ℎ𝑜𝑙𝑑 𝐻𝐸)𝑡  = 0.681 ∙ 𝐸𝐶𝑇𝑡−1 − 0.681 ∙ 𝑃𝑢𝑏𝑙𝑖𝑐 𝐻𝐸𝑡−1 − 0.104∙ 𝐻𝑜𝑢𝑠𝑒ℎ𝑜𝑙𝑑 𝐻𝐸𝑡−1 − 0.002 
Table 6: Co-integration equation and VEC model results between Greek public 
expenditure and household health expenditure 
 
 
 
Source: ELSTAT (HBS raw data of 1988-2018) 
 
The above-mentioned results suggest that there is statistically significant co-
integration between public expenditure and private household spending. Public 
expenditure (GDP) coefficient in the co-integration equation is statistically significant, 
so are the adjustment parameters. The adjustment parameters in this bilateral 
example are easy to be interpreted and one can notice that the estimates have the 
correct signs (negative) and indicate rapid adjustment toward equilibrium, showing 
that as public health expenditures increase, private expenditures are reduced 
(negative: b= -22.832, p<0.05). Estimation of coefficient D_V1 (ce1) equals to -0.718 
(p<0.05). Therefore, when the average rate of private expenditure is very high, it 
quickly falls to the level of public expenditure. The estimated coefficient D_GDP (ce1) 
equals to 0.068 (p<0.05) and indicates that the average rate of public spending is 
quickly adapted to the levels of private spending. This means that approximately 
71.8% of the imbalances between private and public expenditure is corrected by 
changes in private spending, while only 6.8% of the imbalances is corrected by changes 
in public spending. 
 
Results clearly indicate a bi-long relationship between private and public 
expenditure, where private spending seems to be adapted more rapidly to public 
spending, while are those who, mainly, correct the imbalance between private and 
public expenditure. 
 
Discussion 
Greek healthcare system faces public funding gap, as a result of the current financial 
crisis and relevant austerity measures being forced. Official data have shown that 
Greece’s GDP has been contracted by 25%2 within the last decade, and this has had 
an impact on health expenditure of Greek households (of already high O.P.P.), as well. 
Based on literature review, it is clear that most OECD countries followed, more or less, 
the same route: increase in spending during pro crisis period and declining afterwards. 
The austerity program, in which Greece entered due to financial crisis, has, indeed, 
significantly affected HHE, as well. 
 
Limitations 
Perhaps the most important limitation of any study concerning private health 
expenditure is the lack of data on informal payments (under the table payments to 
medical staff, etc.) which constitute the phenomenon of shadow economy and make 
the already enormous private health costs in even higher levels. Although part of these 
informal payments is included in HBS, making them more reliable than other surveys, 
                                                 
2 from 242 billion euro in 2008, to 184,70 billion euro in 2018 (ELSTAT, 9/2019) 
in no way they are considered to be representative of the actual size. In addition, 
presented data in this study may not fully reflect Greek health expenditure, given the 
relatively short period of studying. Further research and comparative analysis are 
needed, to identify the impact of Greece’s financial crisis on HHE, whereas the effect 
of economic crisis appears clearer over the longer periods of time. 
 
Conclusions 
The austerity program, in which Greece entered due to financial crisis, significantly 
affected health expenditure. The results of this study showed that the average total 
household expenditure increased fivefold from 1988 to 2008 and from 2008 to 2018 
the average total expenditure of households on health decreased by 24%. 
 
Regarding subsets, it was shown that the average household expenditure on 
medicines, therapeutic appliances and equipment were considerably increased from 
1988 to 2018, while it seemed that it was the only category which was not affected 
significantly by the financial crisis. Similarly, average household spending on hospital 
care increased notably from 1988 to 2018 and was affected very slightly by economic 
crisis. Conversely, average costs for medical services showed an upward trend from 
1988 to 2008 and then, a significant decrease from 2008 to 2018. 
 
As refers to public expenditure, the results showed that there was an increase during 
the period 1988-2010 and decrease during the period 2010 to 2018. In fact, one can 
say that households at the onset of the financial crisis have had reduced health 
expenditure, while the state has been adapted to this situation two years later. 
 
Lastly, the co-integration analysis showed significant co-integration between public 
health expenditure to total household expenditure and significant cointegration 
between public health expenditure and medical and pharmaceutical household 
expenditure. 
 
On the basis that Health Expenditure will sparingly begin to rise, in the foreseeable 
future, it is recommended that Health Policy planning should consider the severe 
impact of population ageing, with simultaneous smaller share of active population, 
which means significant revenue shortfalls and healthcare funding difficulties. 
 
